Loring Wolcott & Coolidge Fiduciary Advisors’s iShares iBonds Dec 2025 Term Corporate ETF IBDQ Stock Holding History
Bought
Maintained
Sold
Other funds holding IBDQ
Loring Wolcott & Coolidge Fiduciary Advisors's IBDQ Position: Q4 2025 in Review
Loring Wolcott & Coolidge Fiduciary Advisors sold out of iShares iBonds Dec 2025 Term Corporate ETF (IBDQ) in Q4 2025, closing a stake of 6,000 shares — an estimated $151K sold.
Loring Wolcott & Coolidge Fiduciary Advisors first reported a position in IBDQ in Q1 2023 and held it in 11 quarters. The position peaked at $188K in Q3 2024. 3 funds tracked by Wall St. Rank hold IBDQ as of Q4 2025.
- Loring Wolcott & Coolidge Fiduciary Advisors reported no remaining iShares iBonds Dec 2025 Term Corporate ETF position as of Q4 2025 after selling out during the quarter.
- Loring Wolcott & Coolidge Fiduciary Advisors sold 6,000 iShares iBonds Dec 2025 Term Corporate ETF shares in Q4 2025, an estimated $151K.
- Loring Wolcott & Coolidge Fiduciary Advisors first reported a position in iShares iBonds Dec 2025 Term Corporate ETF in Q1 2023 and held it in 11 quarters.
- Loring Wolcott & Coolidge Fiduciary Advisors's iShares iBonds Dec 2025 Term Corporate ETF position peaked at $188K in Q3 2024.
- 3 funds tracked by Wall St. Rank held iShares iBonds Dec 2025 Term Corporate ETF as of Q4 2025.
Based on Loring Wolcott & Coolidge Fiduciary Advisors's 13F filing for Q4 2025, filed 28 Jan 2026.